GV Stock Overview
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Genomic Vision Société Anonyme Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.0018 |
| 52 Week High | €0.046 |
| 52 Week Low | €0.0014 |
| Beta | -0.67 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -91.30% |
| 33 Year Change | -99.77% |
| 5 Year Change | -99.32% |
| Change since IPO | -99.99% |
Recent News & Updates
Shareholder Returns
| GV | FR Biotechs | FR Market | |
|---|---|---|---|
| 7D | 0% | -7.7% | -0.3% |
| 1Y | -91.3% | -26.4% | -3.5% |
Return vs Industry: GV underperformed the French Biotechs industry which returned -15.8% over the past year.
Return vs Market: GV underperformed the French Market which returned 3.5% over the past year.
Price Volatility
| GV volatility | |
|---|---|
| GV Average Weekly Movement | 0% |
| Biotechs Industry Average Movement | 6.6% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.2% |
| 10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: GV has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 33 | Aaron Bensimon | www.genomicvision.com |
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company provides FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision S, an automated scanner that develops life science research applications of single DNA molecules analysis and delivers fluorescence imaging; FiberSmart, an analysis software for replication combing assays; and accessories, which include combicoverslips, disposable DNA reservoirs, coverslips stickers, and bench holders. It offers FiberProbes; HexaCard, a genomic vision molecular combing technology offering a streamline one-stop-shop solution for biomanufacturing industries; TeloSizer, a novel tool for measurements of physical telomere length that can be applied to various model organisms; and EasyComb, EasyScan, and EasyComb Plus services.
Genomic Vision Société Anonyme Fundamentals Summary
| GV fundamental statistics | |
|---|---|
| Market cap | €692.90k |
| Earnings (TTM) | -€10.62m |
| Revenue (TTM) | €1.56m |
0.4x
P/S Ratio-0.1x
P/E RatioIs GV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GV income statement (TTM) | |
|---|---|
| Revenue | €1.56m |
| Cost of Revenue | €134.00k |
| Gross Profit | €1.43m |
| Other Expenses | €12.05m |
| Earnings | -€10.62m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Feb 29, 2024
| Earnings per share (EPS) | -0.028 |
| Gross Margin | 91.43% |
| Net Profit Margin | -679.16% |
| Debt/Equity Ratio | -16.5% |
How did GV perform over the long term?
See historical performance and comparison